Picture of Thermo Fisher Scientific logo

TMO Thermo Fisher Scientific Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareConservativeLarge CapHigh Flyer

Annual cashflow statement for Thermo Fisher Scientific, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-KPRESS
Standards:
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line7,7286,9605,9556,3386,721
Depreciation
Amortisation
Deferred Taxes
Non-Cash Items1,187857882809765
Unusual Items
Other Non-Cash Items
Changes in Working Capital-1,548-1,049-537-379-1,808
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Cash from Operating Activities9,3129,1548,4068,6677,819
Capital Expenditures-2,523-2,243-1,479-1,400-1,525
Purchase of Fixed Assets
Other Investing Cash Flow Items-19,40984-3,663-4,441-2,522
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-21,932-2,159-5,142-5,841-4,047
Financing Cash Flow Items-91-95619490
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities6,581-2,810-3,622-6,7921,801
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-5,8454,046-440-4,0575,839